BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18535809)

  • 1. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
    Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
    Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
    Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
    Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S; Maeda S; Raksakait K; Petchclai B
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy].
    Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX
    Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
    De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
    Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B].
    Jiang YG; Wang YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):337-40. PubMed ID: 15231205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine.
    Amirzargar AA; Mohseni N; Shokrgozar MA; Arjang Z; Ahmadi N; Yousefi Behzadi M; Amanzadeh A; Shokri F
    Iran J Immunol; 2008 Jun; 5(2):92-9. PubMed ID: 18523354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue].
    Kotalová R; Vraná M; Dobrovolná M; Nevoral J; Loudová M
    Cas Lek Cesk; 2002 Aug; 141(16):518-22. PubMed ID: 12404952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
    Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
    J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.